Cannabis Europa – Science, Policy & Business Decision Makers meet in London

by Redaktion

Cannabis Europa is scheduled to take place in London on 25-26 June, 2024. It is Europe’s foremost conference series that connects influential leaders in science, policy and business, helping to build a responsible and effective European cannabis industry that nurtures access and growth. 

With a focus on innovation, regulation, and investment opportunities within the rapidly evolving cannabis industry, the conference serves as a platform for business leaders, policymakers, investors, patients and advocates to collaborate and drive progress.

Our readers get 10% discount with KRAUTINVEST10.

Europe’s medical cannabis market is forecast to be worth almost €2.2 billion and will serve almost 1.5 million patients in the region by 2027, according to forecasts published by Prohibition Partners in The European Cannabis Report: 8th Edition.

Curaleaf International, a market-leading global cannabis company, is the headline partner for the conference and expo. As the Headline Partner for Cannabis Europa, Curaleaf International brings its unparalleled expertise and commitment to advancing the medical cannabis industry in Europe. 

“We are excited to partner with Cannabis Europa for this ground-breaking event,” said Juan Martinez, Head of Curaleaf International.””As a leading global cannabis company, we are deeply committed to driving positive change and shaping the future of the industry. Cannabis Europa provides an invaluable platform for collaboration, innovation, and education, and we look forward to contributing to meaningful discussions and insights at the conference.”

Cannabis Europa in London will feature a diverse lineup of speakers, including executive chairman of Curaleaf, Boris Jordan; tennis legend and CBD brand owner, Pat Cash; and Greek Minister of Health, Adonis Georgiadis. 

On the evolution of the European cannabis industry, Boris Jordan said: “The passage of the Cannabis Act in Germany represents a watershed moment for patients and future adult-use consumers alike. This legislation has set the standard for future cannabis regulatory programs across all of Europe and serves as a wakeup call to U.S. politicians and our regulatory agencies, who continue to stall progress. Curaleaf’s significant investment over three years, established cultivation infrastructure in Portugal, patient platform and complete brand portfolio, ensures we are ready to capitalise on the massive opportunity in Europe.” 

Minster for Health in Greece, Adonis Georgiadis, said: “The European cannabis sector is experiencing dynamic growth and regulatory evolution, with increasing acceptance and legalisation driving opportunities in medical, wellness, and recreational markets, yet it faces challenges in harmonising regulations across different countries.” 

For more information about Cannabis Europa and to register for the conference, please visit:

Disclaimer: This article is part of a media partnership. Our readers get 10% discount with KRAUTINVEST10.

Leave a Comment